Dr. Ballantyne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin
B160
Houston, TX 77030Phone+1 713-798-5034Fax+1 800-526-3384
Education & Training
- Baylor College of MedicineFellowship, Cardiovascular Disease, 1985 - 1988
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1983 - 1985
- University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1982 - 1983
- Baylor College of MedicineClass of 1982
Certifications & Licensure
- TX State Medical License 1983 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Elected Member The American Society for Clinical Investigation, 2000
- Join now to see all
Clinical Trials
- Atherosclerosis Risk in Communities (ARIC) Start of enrollment: 1985 Jul 01
- Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) Start of enrollment: 2004 Apr 01
- Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome. Start of enrollment: 2007 Mar 01
Publications & Presentations
PubMed
- 55 citationsReproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer AssayAdrienne Tin, Bing Yu, Jianzhong Ma, Kunihiro Masushita, Natalie Daya
The Journal of Applied Laboratory Medicine. 2019-07-01 - 32 citationsBempedoic Acid (ETC-1002): A Current Review.Anum Saeed, Christie M. Ballantyne
Cardiology Clinics. 2018-05-01 - 199 citationsBempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapyChristie M. Ballantyne, Ulrich Laufs, Kausik K. Ray, Lawrence A. Leiter, Harold E. Bays
European Journal of Preventive Cardiology. 2020-04-01
Journal Articles
- Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular EventsSalim S Virani, Vijay Nambi, Christie M Ballantyne, JAMA Cardiology
- Association of Circulating Monocyte Chemoattractant Protein–1 Levels with Cardiovascular MortalityChristie M Ballantyne, Emelia J Benjamin, JAMA Cardiology
- Molecular Signature of Multisystem Cardiometabolic Stress and Its Association with PrognosisVenkatesh L Murthy, Christie M Ballantyne, Jane E Freedman, JAMA Cardiology
- Join now to see all
Abstracts/Posters
- [Board 417] Lipid-Lowering Therapy in Different Regions of the United States: Insights From Getting to an ImprOved Understanding of Low-Density Lipoprotein Cholesterol...Christie Ballantyne, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- Why Exactly is the Diabetic Heart Different?2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Beyond LDL-C: Triglycerides and Lp(a) as Target of Lipid Lowering2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Faculty2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Authored Content
- Molecular Signature of Multisystem Cardiometabolic Stress and Its Association with PrognosisJuly 2020
- Molecular Signature of Multisystem Cardiometabolic Stress and Its Association with PrognosisJuly 2020
Press Mentions
- Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a LifetimeOctober 14th, 2024
- A Healthy Fireside Chat with Arianna Huffington and Joseph G. RogersAugust 30th, 2024
- Bringing Together Science and the Lived Experience at Family Heart Global SummitAugust 21st, 2024
- Join now to see all
Grant Support
- T Cells, Macrophages, Chemokines, And Adiposopathy In Diet-Induced ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- Effect Of Lipid Modification On Peripheral Arterial Disease After EndovasculaNational Center For Research Resources2008–2011
- Genetics And Personalized Medicine: From Population Studies To Clinical TherapyNational Heart, Lung, And Blood Institute2009–2010
- Obesity, Inflammation And Thrombosis: Look AheadNational Heart, Lung, And Blood Institute2007–2010
- Effect Of Lipid Modification On Peripheral Arterial Disease (PAD)National Heart, Lung, And Blood Institute2007
- MAC 1/Lfa 1/P150 95 And PMN Leukocyte FunctionNational Heart, Lung, And Blood Institute2000–2002
- Inflammation Of Reperfused Heart: Gene DeletionNational Heart, Lung, And Blood Institute2000–2002
- Community And Cohort Surveillance ProgramDivision Of Epidemiology And Clinical Applications1999–2000
- Leukocyte Adhesion Molecules And Leukocyte FunctionNational Heart, Lung, And Blood Institute1999
- Gene Deletion In Inflammation Of Reperfused HeartNational Heart, Lung, And Blood Institute1995–1999
- SCOR In ArteriosclerosisNational Heart, Lung, And Blood Institute1996
- Neutrophil Adherence Determinants In Myocardial Reperfusion InjuryNational Heart, Lung, And Blood Institute1992–1994
- Molecular Studies Of Endothelial Adhesion MoleculesNational Heart, Lung, And Blood Institute1990–1994
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: